This suggests that administering a booster dose of ancestral S protein (in the context of either a homologous or a heterologous triple vaccination strategy) or a natural infection combined with a double ancestral S dose can yield superior humoral immunity both against the original and a heavily mutated SARS-CoV-2 virus. Here, PROS1 is linked to infection.